Cortalix Awarded SNN Grant for Next-Generation ELISA

We are pleased to announce that Cortalix has been awarded a grant from the Northern Netherlands Regional Development Agency (SNN) to support our project aimed at improving VHH-based ELISAs for prostate cancer. Using our advanced VHH antibody discovery platform, we...